Showing results (921-930 of 999) with videos related to
Sort By:
Pageof 100
Anticancer Research|July 31, 2020
Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In VitroToru Hisaka, Hisamune Sakai, Toshihiro Sato, et al.The Journal of Allergy and Clinical Immunology|September 13, 2020
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validationKoichiro Asano, Akira Hebisawa, Takashi Ishiguro, et al.Biochemical and Biophysical Research Communications|May 2, 2026
USP40 protects podocytes by deubiquitylating integrin β1Naoaki Mikami, Toshiaki Fukushima, Hiromu Takematsu, et al.Plos One|March 24, 2016
Association between Smoking Status and Obesity in a Nationwide Survey of Japanese AdultsTaku Watanabe, Ichizo Tsujino, Satoshi Konno, et al.Journal of the American Society of Nephrology : JASN|August 19, 2022
A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2Ichiro Hada, Akira Shimizu, Hiromu Takematsu, et al.Community Dental Health|August 13, 2015
Association between dental status and food diversity among older JapaneseM Iwasaki, Y Kimura, A Yoshihara, et al.Cancer Science|April 14, 2015
Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC StudyHiroki Yamaue, Takuya Tsunoda, Masaji Tani, et al.Geriatrics & Gerontology International|June 18, 2022
Older adults' preferences for and actual situations of artificial hydration and nutrition in end-of-life care: An 11-year follow-up study in a care homeTaizo Wada, Yasuko Ishimoto, Kiichi Hirayama, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 25, 2020
FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in JapanNoritoshi Kobayashi, Katsuhiro Omae, Yosuke Horita, et al.Cancer Science|November 18, 2018
Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOXHiromichi Shirasu, Akiko Todaka, Katsuhiro Omae, et al.Pageof 100